FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results
unknown
📅 Published: 2026-03-06 09:53
📰 Source: Benzinga
📝 Words: 18
📝 Article Content
FDA approves Johnson & Johnson's Tecvayli with Darzalex Faspro for multiple myeloma after strong Phase 3 survival results.
📄 Summary
FDA approves Johnson & Johnson's Tecvayli with Darzalex Faspro for multiple myeloma after strong Phase 3 survival results.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-03-13 18:10:42
Updated At:
2026-03-13 18:10:42
Scraping Job ID:
N/A
Stock Mentions:
AMP - Ameriprise Financial Inc.
Relevance: N/A